Shield Therapeutics PLC logo

Shield Therapeutics PLC

NEW
LSE:STX (UK)  
£ 0.063 (0%) Jul 14
At Loss
Market Cap:
£ 66.84M ($ 89.58M)
Enterprise V:
£ 80.87M ($ 108.37M)
Volume:
390.93K
Avg Vol (2M):
1.42M
Trade In:
Volume:
390.93K
At Loss

Shield Therapeutics PLC (LSE:STX) Dividend

Shield Therapeutics PLC (LSE:STX) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -60.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: LSE:STX Dividend

Does Shield Therapeutics PLC (LSE:STX) pay a dividend?

Shield Therapeutics PLC (LSE:STX) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Shield Therapeutics PLC pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Shield Therapeutics PLC has returned capital to shareholders via buybacks at a rate of -60.3% over the past 3 years.

What are dividend-paying alternatives to Shield Therapeutics PLC?

For dividend-paying alternatives in Shield Therapeutics PLC's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.